Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3400
0.00 (0.00%)
Last updated: Aug 28, 2026, 2:11 PM AEST

Cleo Diagnostics Statistics

Total Valuation

ASX:COV has a market cap or net worth of AUD 46.62 million. The enterprise value is 40.39 million.

Market Cap46.62M
Enterprise Value 40.39M

Important Dates

The last earnings date was Thursday, August 27, 2026.

Earnings Date Aug 27, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:COV has 137.11 million shares outstanding. The number of shares has increased by 3.28% in one year.

Current Share Class 137.11M
Shares Outstanding 137.11M
Shares Change (YoY) +3.28%
Shares Change (QoQ) +6.42%
Owned by Insiders (%) 32.31%
Owned by Institutions (%) n/a
Float 80.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 27.15
PB Ratio 9.30
P/TBV Ratio 9.92
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 23.52
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.80

Current Ratio 3.80
Quick Ratio 3.79
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -109.48% and return on invested capital (ROIC) is -65.48%.

Return on Equity (ROE) -109.48%
Return on Assets (ROA) -52.15%
Return on Invested Capital (ROIC) -65.48%
Return on Capital Employed (ROCE) -113.38%
Weighted Average Cost of Capital (WACC) 6.24%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.25
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -5.56% in the last 52 weeks. The beta is 0.36, so ASX:COV's price volatility has been lower than the market average.

Beta (5Y) 0.36
52-Week Price Change -5.56%
50-Day Moving Average 0.40
200-Day Moving Average 0.55
Relative Strength Index (RSI) 44.67
Average Volume (20 Days) 94,791

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:COV had revenue of AUD 1.72 million and -5.94 million in losses. Loss per share was -0.04.

Revenue1.72M
Gross Profit 1.72M
Operating Income -5.68M
Pretax Income -5.94M
Net Income -5.94M
EBITDA -5.62M
EBIT -5.68M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 6.22 million in cash and no debt, with a net cash position of 6.22 million or 0.05 per share.

Cash & Cash Equivalents 6.22M
Total Debt n/a
Net Cash 6.22M
Net Cash Per Share 0.05
Equity (Book Value) 5.01M
Book Value Per Share 0.04
Working Capital 4.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.94 million and capital expenditures -9,421, giving a free cash flow of -4.95 million.

Operating Cash Flow -4.94M
Capital Expenditures -9,421
Depreciation & Amortization 64,386
Net Borrowing n/a
Free Cash Flow -4.95M
FCF Per Share -0.04
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -330.81%
Pretax Margin -345.72%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ASX:COV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.28%
Shareholder Yield -3.28%
Earnings Yield -12.73%
FCF Yield -10.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:COV has an Altman Z-Score of 19.68 and a Piotroski F-Score of 2.

Altman Z-Score 19.68
Piotroski F-Score 2